- Leadership at the Centre of Africa’s Investment Story
- Delisting and take-private trend is a sign of progress rather than crisis for South Africa
- Energy: The Cornerstone of Africa's Infrastructure Development
- Powering Africa's Industrialisation Through Energy and Infrastructure Development
- Will AI disrupt the payments industry in 2026? Izak van Heerden, Senior Manager: Development at Altron FinTech
FDA Moving at ‘Lightning Speed’ on Gilead Virus Drug, Hahn Says
NEW YORK (Capital Markets in Africa) — The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial. “We’re working with the company to emphasize the necessity of speed while at the same time to understand the data,” Hahn said in an interview. “There will be a lot of factors that go…
Read More







